Nucl Med Mol Imaging.  2019 Jun;53(3):167-171. 10.1007/s13139-019-00586-x.

Perspectives for Concepts of Individualized Radionuclide Therapy, Molecular Radiotherapy, and Theranostic Approaches

• Hosono M

• KMID: 2450006
• DOI: http://doi.org/10.1007/s13139-019-00586-x

Abstract

Radionuclide therapy (RNT) stands on the delivery of radiation to tumors or non-tumor target organs using radiopharmaceuticals that are designed to have specific affinity to targets. RNT is recently called molecular radiotherapy (MRT) by some advocators in order to emphasize its characteristics as radiotherapy and the relevance of dosimetry-guided optimization of treatment. Moreover, RNT requires relevant radiation protection standards because it employs unsealed radionuclides and gives therapeutic radiation doses in humans. On the basis of these radiation protection standards, the development and use of radiopharmaceuticals for combined application through diagnostics and therapeutics lead to theranostic approaches that will enhance the efficacy and safety of treatment by implementing dosimetry-based individualization.

Keyword

Radionuclide therapy; Theranostics; Radiopharmaceuticals

MeSH Terms

Humans
Radiation Protection
Radioisotopes
Radiopharmaceuticals
Radiotherapy*
Theranostic Nanomedicine*
Radioisotopes
Radiopharmaceuticals